Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c984 |
|---|---|
| Identifier | NCT05731128 |
| Trial Title | A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab)) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis Ulcerative |
| Interventions | DRUG: Dupilumab|DRUG: Placebo |
Participant Information
| Sponsor | Sanofi |
|---|---|
| City | Apple Valley |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2023-01-12 |
|---|---|
| Primary Completion Date | 2026-05-15 |
| Completion Date | 2027-02-19 |